Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $55.00 | $5.50/mg | In stock | Jul 27 |
| vial | 20mg | $99.00 | $4.95/mg | In stock | Jul 27 |
| vial | 40mg | $187.00 | $4.67/mg | In stock | Jul 27 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| 665394 | Apr 2026 | 99.2% | Freedom Diagnostics | Endotoxin | Confirmed | View |
Removed from Category 2 on April 22, 2026; in no FDA category today. On the July 23–24, 2026 PCAC advisory docket for ulcerative colitis — not authorized for compounding. The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything — removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all. The Pharmacy Compounding Advisory Committee is advisory only — it met July 23–24, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 6–18 months afterward. Listing decisions are specific to the proposed use.
Does Blank Peptides sell BPC-157?
Yes — Blank Peptides currently lists BPC-157 in 3 variants starting at $187.00 ($4.67/mg).
Is Blank Peptides's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 2 Certificates of Analysis for Blank Peptides's BPC-157, with the most recent showing 99.2% purity. Blank Peptides holds an overall trust grade of B (80/100) across all 138 COAs on file.
What is Blank Peptides's trust grade for BPC-157?
Blank Peptides has an overall Disclosed Labs trust grade of B (80/100), computed from 138 COAs across all peptides. The most recent BPC-157 COA was issued by Freedom Diagnostics.
Where is the cheapest BPC-157?
As of the latest data, Peptide Supply Co. offers BPC-157 at $2.25/mg — compare with Blank Peptides's listing at $4.67/mg. See the full BPC-157 price comparison.
What is the FDA compounding status of BPC-157?
Removed from Category 2 on April 22, 2026; in no FDA category today. On the July 23–24, 2026 PCAC advisory docket for ulcerative colitis — not authorized for compounding. The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything — removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all. The Pharmacy Compounding Advisory Committee is advisory only — it met July 23–24, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 6–18 months afterward. Listing decisions are specific to the proposed use. Sales tracked here are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| BPCC-052026-7 | — | 100.0% | Freedom Diagnostics | Endotoxin | Confirmed | View |
Disclosed Labs